These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

577 related items for PubMed ID: 21771626

  • 1. Pekin and Muscovy ducks respond differently to vaccination with a H5N1 highly pathogenic avian influenza (HPAI) commercial inactivated vaccine.
    Cagle C, To TL, Nguyen T, Wasilenko J, Adams SC, Cardona CJ, Spackman E, Suarez DL, Pantin-Jackwood MJ.
    Vaccine; 2011 Sep 02; 29(38):6549-57. PubMed ID: 21771626
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Vaccination of domestic ducks against H5N1 HPAI: a review.
    Pantin-Jackwood MJ, Suarez DL.
    Virus Res; 2013 Dec 05; 178(1):21-34. PubMed ID: 23916865
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of a Recombinant Turkey Herpesvirus H5 Vaccine Against Challenge With H5N1 Clades 1.1.2 and 2.3.2.1 Highly Pathogenic Avian Influenza Viruses in Domestic Ducks (Anas platyrhynchos domesticus).
    Pantin-Jackwood MJ, Kapczynski DR, DeJesus E, Costa-Hurtado M, Dauphin G, Tripodi A, Dunn JR, Swayne DE.
    Avian Dis; 2016 Mar 05; 60(1):22-32. PubMed ID: 26953940
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prime-boost vaccination with a fowlpox vector and an inactivated avian influenza vaccine is highly immunogenic in Pekin ducks challenged with Asian H5N1 HPAI.
    Steensels M, Bublot M, Van Borm S, De Vriese J, Lambrecht B, Richard-Mazet A, Chanavat-Bizzini S, Duboeuf M, Le Gros FX, van den Berg T.
    Vaccine; 2009 Jan 29; 27(5):646-54. PubMed ID: 19056442
    [Abstract] [Full Text] [Related]

  • 9. Immune responses and protection against H5N1 highly pathogenic avian influenza virus induced by the Newcastle disease virus H5 vaccine in ducks.
    Ferreira HL, Pirlot JF, Reynard F, van den Berg T, Bublot M, Lambrecht B.
    Avian Dis; 2012 Dec 29; 56(4 Suppl):940-8. PubMed ID: 23402116
    [Abstract] [Full Text] [Related]

  • 10. Recombinant Turkey Herpesvirus-AI Vaccine Virus Replication in Different Species of Waterfowl.
    Palya V, Kovács EW, Tatár-Kis T, Felföldi B, Homonnay ZG, Mató T, Sato T, Gardin Y.
    Avian Dis; 2016 May 29; 60(1 Suppl):210-7. PubMed ID: 27309057
    [Abstract] [Full Text] [Related]

  • 11. A conventional, inactivated oil emulsion vaccine suppresses shedding and prevents viral meat colonisation in commercial (Pekin) ducks challenged with HPAI H5N1.
    Beato MS, Toffan A, De Nardi R, Cristalli A, Terregino C, Cattoli G, Capua I.
    Vaccine; 2007 May 16; 25(20):4064-72. PubMed ID: 17420074
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Transmission of highly pathogenic avian influenza H5N1 virus in Pekin ducks is significantly reduced by a genetically distant H5N2 vaccine.
    van der Goot JA, van Boven M, Stegeman A, van de Water SG, de Jong MC, Koch G.
    Virology; 2008 Dec 05; 382(1):91-7. PubMed ID: 18848343
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Protective Efficacy of Recombinant Turkey Herpes Virus (rHVT-H5) and Inactivated H5N1 Vaccines in Commercial Mulard Ducks against the Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.2.1 Virus.
    Kilany WH, Safwat M, Mohammed SM, Salim A, Fasina FO, Fasanmi OG, Shalaby AG, Dauphin G, Hassan MK, Lubroth J, Jobre YM.
    PLoS One; 2016 Dec 05; 11(6):e0156747. PubMed ID: 27304069
    [Abstract] [Full Text] [Related]

  • 16. Vaccination against highly pathogenic avian influenza H5N1 virus in zoos using an adjuvanted inactivated H5N2 vaccine.
    Philippa J, Baas C, Beyer W, Bestebroer T, Fouchier R, Smith D, Schaftenaar W, Osterhaus A.
    Vaccine; 2007 May 10; 25(19):3800-8. PubMed ID: 17403559
    [Abstract] [Full Text] [Related]

  • 17. A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques.
    Itoh Y, Ozaki H, Tsuchiya H, Okamoto K, Torii R, Sakoda Y, Kawaoka Y, Ogasawara K, Kida H.
    Vaccine; 2008 Jan 24; 26(4):562-72. PubMed ID: 18164788
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of commercial vaccines in protecting chickens and ducks against H5N1 highly pathogenic avian influenza viruses from Vietnam.
    Pfeiffer J, Suarez DL, Sarmento L, To TL, Nguyen T, Pantin-Jackwood MJ.
    Avian Dis; 2010 Mar 24; 54(1 Suppl):262-71. PubMed ID: 20521643
    [Abstract] [Full Text] [Related]

  • 19. Multiple dose vaccination with heterologous H5N2 vaccine: immune response and protection against variant clade 2.2.1 highly pathogenic avian influenza H5N1 in broiler breeder chickens.
    Abdelwhab EM, Grund C, Aly MM, Beer M, Harder TC, Hafez HM.
    Vaccine; 2011 Aug 26; 29(37):6219-25. PubMed ID: 21745517
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.